| Literature DB >> 24294834 |
Mohammadreza Shaghaghi1, Nima Parvaneh, Pouya Ostad-Rahimi, Seyed Mohammad Fathi, Shohreh Shahmahmoodi, Hassan Abolhassani, Asghar Aghamohammadi.
Abstract
Neurologic abnormalities compatible with vaccine-related poliovirus infection (VAPP) may be a first presentation of some primary immunodeficient patients. The risk of VAPP rises from 1 case per 750 000 in normal population to 1 per 7000 times higher, particularly for persons with agammaglobulinemia and hypogammaglobulinemia. However, there is no appropriate estimation for VAPP occurrence in patients with cellular immunity defects. Herein we report a case of combined immunodeficiency with paralytic complication due to oral polio vaccine and we present a literature review on this topic.Entities:
Mesh:
Substances:
Year: 2013 PMID: 24294834 DOI: 10.3109/08820139.2013.859156
Source DB: PubMed Journal: Immunol Invest ISSN: 0882-0139 Impact factor: 3.657